Patent ID: 11918652
Assignee: NANOBACTERIE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G | IPC A  G

Claim 3:
4. The method according to claim 1,
wherein the acoustic wave is an unfocused acoustic wave having at least one property selected from the group consisting of:
i) the unfocused acoustic wave covers more than 10−5% by volume of the body part, using less than 103 application spots,
ii) the unfocused acoustic wave is applied over an acoustic wave volume that is larger than 10−10 cm3,
iii) the unfocused acoustic wave is applied over an acoustic wave volume that is larger than the nanoparticle region to which nanoparticles have been administered, a body part, a healthy site, or a pathological site, and
iv) the unfocused acoustic wave is applied over an acoustic wave volume that is larger, than an acoustic wave volume that is reached by or exists with or results from a focused acoustic wave or the application of a focused acoustic wave,
wherein each of the application spots is defined as the acoustic volume that is covered during a single application of acoustic wave or during one sequence,
wherein the acoustic wave volume is one of a volume, that is exposed to the acoustic wave, a volume that receives the acoustic wave energy, or a volume that undergoes the effects of the acoustic wave,
wherein the healthy site is a site of the individual that comprises healthy cell(s),
wherein the pathological site is a site of the individual that comprises pathological cell(s),
wherein the acoustic volume of a focused acoustic wave is a volume that covers less than 105% by volume of the body part, using more than 1 application spot or is a volume covered by a high intensity focused ultrasound.